Small Molecules

15 Mar 2017 Catalyst Pharmaceuticals Announces Positive Data from Investigator-Sponsored Trial of Firdapse(R) in treating MuSK Antibody Positive Myasthenia Gravis
15 Mar 2017 Lynparza Phase III SOLO-2 data demonstrate progression-free survival benefit in BRCA-mutated ovarian cancer as maintenance therapy
14 Mar 2017 MetrioPharm Announces Positive Top-Line Results from a Phase IIa Study in Moderate-to-Severe Psoriasis with its Oral Lead Compound MP1032
14 Mar 2017 twoXAR Announces Preclinical Proof-of-Concept Data on Novel Liver Cancer Candidate
14 Mar 2017 LSK BioPharma Announces Enrollment of First Patient in Phase 3 Apatinib Trial in Gastric Cancer
14 Mar 2017 Sunovion Submits Supplemental New Drug Application to FDA for Use of APTIOM® (eslicarbazepine acetate) for the Treatment of Partial-Onset Seizures in Children 4 Years of Age and Older
14 Mar 2017 Novartis Kisqali® (ribociclib, LEE011) receives FDA approval as first-line treatment for HR+/HER2- metastatic breast cancer in combination with any aromatase inhibitor
13 Mar 2017 Clovis Oncology Presents New Data from Phase 2 Studies of Rucaparib in Advanced Ovarian Cancer at 2017 SGO Annual Meeting on Women’s Cancer
13 Mar 2017 Karyopharm Announces Partial Clinical Hold to Pause Enrollment in Selinexor Trials
12 Mar 2017 BeiGene Announces Initiation of Pivotal Study in China with BTK Inhibitor BGB-3111 in Patients with Relapsed or Refractory CLL/SLL
12 Mar 2017 New Phase 2 studies with filgotinib in small bowel and fistulizing Crohn's disease
09 Mar 2017 Tyrogenex Completes Patient Enrollment in its Phase 2 Trial of Orally Administered Vorolanib for Wet Age-related Macular Degeneration
09 Mar 2017 Nicox resubmits AC-170 (ZERVIATE1) NDA to the U.S. FDA
08 Mar 2017 BerGenBio Enters Collaboration With MSD Focused on Clinical Evaluation of BGB324 in Combination With KEYTRUDA® (Pembrolizumab) in Advanced Lung and Breast Cance
08 Mar 2017 Menlo Therapeutics Announces Successful Pruritus Reduction Results from Phase 2 Serlopitant Trial (TCP-102) in 127 Subjects With Prurigo Nodularis
08 Mar 2017 Regenacy Pharmaceuticals Demonstrates Reversal of Chemotherapy-Induced Peripheral Neuropathy with HDAC6 Inhibitor Ricolinostat in Preclinical Model
08 Mar 2017 Glenmark Pharmaceuticals Receives FDA Clearance of IND for GSP 304
07 Mar 2017 Daiichi Sankyo Initiates ENTRUST-AF PCI Study Investigating Once-Daily Lixiana® (edoxaban) in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention with Stenting
07 Mar 2017 Actelion is granted marketing authorization by the European Commission for Ledaga (chlormethine gel) for the treatment of MF-CTCL
07 Mar 2017 Samumed Presented Data on Increases in Hair Follicles Observed in Its Phase 2 Biopsy Study for a Potential Treatment of Androgenetic Alopecia (AGA) at Annual Meeting of the American Academy of Dermatology (AAD)
07 Mar 2017 Concert Pharmaceuticals Presents CTP-543 Phase 1 Results at American Academy of Dermatology Annual Meeting
07 Mar 2017 Oral OTEZLA® (Apremilast) Demonstrated Significant Improvement versus Placebo in Trial of Patients with Moderate Plaque Psoriasis Who Were Naïve to Systemic and Biologic Therapy
07 Mar 2017 Deciphera Pharmaceuticals Initiates a Phase 1 Clinical Trial of DCC-3014 in Patients with Advanced Malignancies
04 Mar 2017 SCYNEXIS delays initiation of new clinical studies using the IV formulation of SCY-078 at FDA's request
03 Mar 2017 Chi-Med Announces Positive Top-Line Results for FRESCO, its Phase III Pivotal Registration Trial of Fruquintinib in Patients with Locally Advanced or Metastatic Colorectal Cancer

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing